The Measures to Optimize RAAS-blockade in Patients with Hyperkalemia and Chronic Kidney Disease
Latest Information Update: 20 Feb 2024
At a glance
- Drugs Losartan (Primary) ; Patiromer (Primary) ; Spironolactone (Primary)
- Indications Hyperkalaemia; Renal failure
- Focus Therapeutic Use
- Acronyms MorphCKD
- 16 Feb 2024 Status changed from recruiting to completed.
- 12 Sep 2023 Planned number of patients changed from 128 to 140.
- 28 Jul 2020 New trial record